行情

BIO

BIO

Bio Rad实验室
NYSE

实时行情|Nasdaq Last Sale

369.97
-5.37
-1.43%
盘后: 369.97 0 0.00% 16:00 01/24 EST
开盘
376.13
昨收
375.34
最高
376.13
最低
368.27
成交量
8.66万
成交额
--
52周最高
391.22
52周最低
235.52
市值
110.75亿
市盈率(TTM)
35.06
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

BIO 新闻

  • Arpeggio Bio完成320万美元种子轮融资
  • 东方财富网.01/17 09:09
  • The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx
  • Benzinga.01/10 12:13
  • The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results
  • Benzinga.01/09 13:43
  • Is Bio-Rad Laboratories, Inc.'s (NYSE:BIO) ROE Of 7.3% Concerning?
  • Simply Wall St..01/09 10:40

更多

所属板块

医疗设备、用品及经销
-0.74%
医疗设备和用品
-0.90%

热门股票

名称
价格
涨跌幅

BIO 简况

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
展开

Webull提供Bio-Rad Laboratories, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。